INS and myeloid sarcoma: Thus, a novel insulin resistance (IRAR) index was proposed by integration of the AR index into an existing insulin resistance index to provide a more promising biomarker of insulin sensitivity for early diagnosis of T2DM and MS in the daily clinical practice and for large-scale clinical investigation.